You just got a question wrong on Neisseria gonorrhoeae and the explanation felt… too short. Classic. The fastest way to stop missing these is to treat every answer choice like a mini–board review: why the correct option is correct, and why each distractor is tempting—but wrong. Let’s do that with a high-yield gonorrhea vignette the way it shows up on Step 1/2.
Tag: Microbiology > Gram-Negative Bacteria
The Vignette (Q-bank style)
A 19-year-old sexually active woman presents with 2 days of dysuria and increased vaginal discharge. She denies fever. Pelvic exam shows mucopurulent endocervical discharge and cervical friability. NAAT from a cervical swab is positive for a gram-negative organism. The clinician treats her empirically and counsels partner treatment.
Which virulence factor most directly helps this pathogen evade host immune defenses through antigenic variation?
A. IgA protease
B. Lipooligosaccharide (LOS) endotoxin
C. Pili (type IV)
D. Polysaccharide capsule
E. Protein A
The Correct Answer: C. Pili (type IV)
Why it’s correct: Neisseria gonorrhoeae uses type IV pili for:
- Attachment to mucosal epithelium (urethra, endocervix, rectum, pharynx)
- Twitching motility
- Immune evasion via antigenic variation (frequent changes in pilin proteins)
This antigenic variation is a big reason:
- People can get reinfected repeatedly
- Natural infection does not produce durable protective immunity
- Vaccine development has been difficult
High-yield tie-in: Neisseria also varies Opa proteins, but on most NBME/Q-bank items, the “antigenic variation” slam dunk for gonorrhea is pili.
Why the Other Choices Are Wrong (and What They’re Testing)
A. IgA protease — Tempting, but not the mechanism here
Why it tempts you: Neisseria species are famous for mucosal infection, and mucosal immunity = IgA.
Why it’s wrong:
IgA protease helps colonization by cleaving secretory IgA in mucosal secretions. It does not mediate antigenic variation.
High-yield associations:
- Produces IgA protease:
- Neisseria gonorrhoeae
- Neisseria meningitidis
- Haemophilus influenzae
- Streptococcus pneumoniae
- Think: “mucosal pathogens that want to break through IgA.”
B. Lipooligosaccharide (LOS) endotoxin — inflammation, not antigen switching
Why it tempts you: Gram-negative = endotoxin.
Why it’s wrong:
Neisseria has LOS (not LPS). It functions like endotoxin and contributes to:
- Local inflammation (cervicitis/urethritis)
- Tissue damage
- In disseminated disease, systemic inflammatory response
But LOS is not the antigenic variation mechanism they’re asking for.
High-yield nuance:
- Neisseria has an outer membrane with LOS.
- LOS can be sialylated, which helps it resist complement-mediated killing (an immune evasion trick), but that’s still not the classic “antigenic variation” answer.
D. Polysaccharide capsule — this is N. meningitidis, not gonorrhoeae
Why it tempts you: “Neisseria” + immune evasion + capsule is a common pairing.
Why it’s wrong:
- Encapsulated: Neisseria meningitidis
- Not encapsulated: Neisseria gonorrhoeae
Capsules are major virulence factors for bloodstream invasion and meningitis, not the usual localized mucosal disease picture.
Board-style contrast:
| Feature | N. gonorrhoeae | N. meningitidis |
|---|---|---|
| Capsule | Absent | Present |
| Classic clinical | Urethritis, cervicitis, PID, neonatal conjunctivitis, septic arthritis | Meningitis, meningococcemia, Waterhouse-Friderichsen |
| Vaccine | No routine vaccine | Capsular conjugate vaccines (ACWY) + MenB |
E. Protein A — that’s Staphylococcus aureus
Why it tempts you: Immune evasion factor name recognition.
Why it’s wrong:
Protein A binds the Fc portion of IgG, flipping antibodies “backwards” so phagocytes can’t opsonize effectively. That is classic for S. aureus (gram-positive cocci), not Neisseria.
High-yield:
- Protein A = anti-opsonization = S. aureus
- Not a gram-negative diplococcus feature
The Core Clinical Syndrome: What “Gonorrhea” Looks Like on Step
Typical presentations
- Male urethritis: purulent discharge + dysuria
- Female cervicitis: mucopurulent discharge, postcoital bleeding, cervical friability
- Often coinfected with Chlamydia trachomatis (important for treatment choices)
Major complications to remember
- PID (endometritis/salpingitis) → infertility, ectopic pregnancy, chronic pelvic pain
- Fitz-Hugh–Curtis syndrome: perihepatitis → RUQ pain, “violin-string” adhesions
- Disseminated gonococcal infection (DGI):
- Migratory polyarthritis
- Tenosynovitis
- Dermatitis (pustular lesions)
- Septic arthritis
Neonatal infection
- Neonatal conjunctivitis (ophthalmia neonatorum)
- Gonorrhea: classically earlier, more severe/purulent
- Prevent with erythromycin eye ointment (prophylaxis at birth)
Lab/ID High-Yield: How They Describe It
Micro description:
- Gram-negative diplococci
- Often described as kidney/coffee bean–shaped
- Frequently intracellular within neutrophils in urethral exudate (esp. men)
Culture/biochem:
- Oxidase positive
- Ferments glucose only (vs N. meningitidis ferments glucose and maltose)
- Thayer-Martin (VPN) selective medium
- Vancomycin (kills gram+)
- Polymyxin (kills other gram−)
- Nystatin (kills fungi)
Testing:
- NAAT is most common for genital infection (and often preferred)
Treatment: What They Want You to Do (Step 2-style)
Because of resistance patterns, empiric therapy is usually:
- Ceftriaxone (for gonorrhea)
- Plus doxycycline if chlamydia hasn’t been excluded
- (Azithromycin is an alternative in some cases, but doxycycline is commonly emphasized in current guidance for chlamydial coverage.)
Also tested heavily:
- Treat sexual partners
- Abstain from sex until completion of therapy (and symptoms resolved)
- Consider test-of-cure in certain scenarios (e.g., pharyngeal infection, pregnancy, persistent symptoms, local resistance concerns)
Quick “Distractor Decoder” for This Topic
When you see N. gonorrhoeae, map answer choices like this:
- Antigenic variation → Pili (type IV) (and Opa proteins as a related concept)
- Mucosal colonization → IgA protease
- Inflammation/endotoxin-like effects → LOS
- Capsule → points you away from gonorrhoeae and toward meningitidis
- Protein A → points you away from Neisseria and toward S. aureus
Takeaway
If the stem screams gonorrhea (mucopurulent cervicitis/urethritis, intracellular GN diplococci, NAAT+), then the classic immune evasion mechanism that explains reinfection and lack of lasting immunity is pili antigenic variation. The distractors are mostly testing whether you can separate: colonization tools (IgA protease), inflammatory triggers (LOS), and meningococcus-only features (capsule) from the actual asked mechanism.